We are live on ! Find out more
NUTX

Nutex Health
NUTX

41 hedge funds and large institutions have $28.7M invested in Nutex Health in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

185% more capital invested

Capital invested by funds: $10.1M → $28.7M (+$18.6M)

37% more funds holding

Funds holding: 30 → 41 (+11)

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

7.51% more ownership

Funds ownership: 9.16% → 16.67% (+7.5%)

Holders
41
Holders Change
+11
Holders Change %
+36.67%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
10
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
+$1.23M
2
AA
Ancora Advisors
Ohio
+$1.2M
3
DWM
Drive Wealth Management
Utah
+$1.01M
4
EIM
Essex Investment Management
Massachusetts
+$941K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$658K

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$865K
2
Renaissance Technologies
Renaissance Technologies
New York
-$63K
3
AAS
Avantax Advisory Services
Texas
-$57K
4
BHWM
Beaird Harris Wealth Management
Texas
-$54.1K
5
TDC
Thompson Davis & Co
Virginia
-$26.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
26
Baader Bank Aktiengesellschaft
Germany
$206K +$185K +6,500 New
Northern Trust
27
Northern Trust
Illinois
$200K +$180K +6,312 New
UBS Group
28
UBS Group
Switzerland
$184K +$123K +4,325 +289%
MCM
29
MAI Capital Management
Ohio
$156K +$140K +4,929 New
Bank of America
30
Bank of America
North Carolina
$65.7K +$58.2K +2,043 +6,590%
BHWM
31
Beaird Harris Wealth Management
Texas
$41.2K -$54.1K -1,900 -59%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$27K +$24.5K +859 New
W
33
WealthCollab
Washington
$26.8K – – –
Morgan Stanley
34
Morgan Stanley
New York
$20.9K +$18.8K +659 New
LFG
35
Larson Financial Group
Missouri
$12.2K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$3.07K – – –
Lazard Asset Management
37
Lazard Asset Management
New York
$3K -$1.03K -36 -25%
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$951 -$2.85K -100 -77%
JP Morgan Chase
39
JP Morgan Chase
New York
$634 -$199 -7 -26%
AP
40
Atwood & Palmer
Missouri
$412 – – –
SS
41
Sunbelt Securities
Texas
$31 – – –
IAIM
42
International Assets Investment Management
Florida
– -$400 -8,680 Closed
NA
43
NewEdge Advisors
Louisiana
– -$8.7K -401 Closed
TRCT
44
Tower Research Capital (TRC)
New York
– -$6.1K -281 Closed
IWP
45
IAG Wealth Partners
Wisconsin
– -$2.17K -100 Closed
DB
46
Danske Bank
Denmark
– -$43 -2 Closed
1
2

NUTX Hedge Fund Activity: Q4 2024 in Review

41 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q4 2024, worth a combined $28.7M — up 185% from $10.1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NUTX positions and 5 closed out — a net gain of 11 holders — while 10 added to existing stakes and 8 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $1.23M. The largest seller was Marshall Wace, cutting an estimated $865K.

  • 41 institutional investors held Nutex Health (NUTX) as of Q4 2024, up from 30 in Q3 2024.
  • Funds reported $28.7M of Nutex Health stock for Q4 2024, up 185% quarter-over-quarter.
  • 16 funds opened new Nutex Health positions in Q4 2024 and 5 closed out, a net change of +11 holders.
  • The largest Nutex Health buyer in Q4 2024 was American Century Companies, an estimated $1.23M added.
  • The largest Nutex Health seller in Q4 2024 was Marshall Wace, an estimated $865K sold.

Based on aggregated 13F filings for Q4 2024.